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Mcl-1 is a key regulator of the ovarian reserve
S Omari1,2, M Waters1, T Naranian1,2, K Kim1,2, AL Perumalsamy1, M Chi3, E Greenblatt4,5, KH Moley3, JT Opferman6
and A Jurisicova*,1,2,5

A majority of ovarian follicles are lost to natural death, but the disruption of factors involved in maintenance of the oocyte pool
results in a further untimely follicular depletion known as premature ovarian failure. The anti-apoptotic B-cell lymphoma 2 (Bcl-2)
family member myeloid cell leukemia-1 (MCL-1) has a pro-survival role in various cell types; however, its contribution to oocyte
survival is unconfirmed. We present a phenotypic characterization of oocytes deficient in Mcl-1, and establish its role in
maintenance of the primordial follicle (PMF) pool, growing oocyte survival and oocyte quality. Mcl-1 depletion resulted in the
premature exhaustion of the ovarian reserve, characterized by early PMF loss because of activation of apoptosis. The increasingly
diminished surviving cohort of growing oocytes displayed elevated markers of autophagy and mitochondrial dysfunction. Mcl-1deficient ovulated oocytes demonstrated an increased susceptibility to cellular fragmentation with activation of the apoptotic
cascade. Concomitant deletion of the pro-apoptotic Bcl-2 member Bcl-2-associated X protein (Bax) rescued the PMF phenotype
and ovulated oocyte death, but did not prevent the mitochondrial dysfunction associated with Mcl-1 deficiency and could not
rescue long-term breeding performance. We thus recognize MCL-1 as the essential survival factor required for conservation of the
postnatal PMF pool, growing follicle survival and effective oocyte mitochondrial function.
Cell Death and Disease (2015) 6, e1755; doi:10.1038/cddis.2015.95; published online 7 May 2015

Estimates of the human primordial follicle (PMF) reservoir, the
size of which dictates the extent of the ovarian reserve,
indicates the presence of at least half a million oocytes per
ovary at birth.1,2 The essential decision that PMFs face is
either long-term arrest with a possibility of recruitment toward
the growing pool, or death. Even upon recruitment to the
growing pool, intricately orchestrated crosstalk of survival
signals between ovarian somatic cells and oocytes facilitate
the ovulation of a single oocyte in human in each cycle. Hence,
the default fate for millions of ovarian germ cells is death,
as only a small fraction survive till ovulation.3 Insufficient
endowment during fetal development or excessive oocyte loss
during postnatal life further limits the ovarian reserve and can
result in an untimely exhaustion of the follicle pool leading to
premature ovarian failure (POF); a syndrome that affects
around 1% of all women, with a higher prevalence (up to 30%)
in families with heritable traits of this condition.4,5 Mechanisms
responsible for maintenance of the follicular reserve are poorly
understood, however, biological assessments and mathematical modeling reveal that progressive loss of follicles with age
is non-linear and accelerates, especially after 38 years.6,7 With
a declining ovarian reserve, poor oocyte quality is an
additional factor that contributes to the reduced fertility

associated with increased maternal age. Oocytes and resulting embryos of older mothers have increased rates of
aneuploidies likely due to defects in chromosomal cohesion
and meiotic spindle stability, decreased DNA repair capacity,
altered gene expression, impaired mitochondrial function and
elevated cellular redox, all contributing to increased rates of
cell death.8–10
The marked decline of oocyte number in mammalian
ovaries has been attributed to oocyte loss via stage-specific
modes of death. As yet, perinatal PMF loss in mice most
frequently engages apoptotic cell death,11,12 whereas within
the postnatal ovary, oocytes in growing follicles undergo
atresia, a less 'molecularly' defined death, carrying hallmarks
of both apoptosis and autophagy.13–15 It is thus surprising that
no member of the anti-apoptotic B-cell lymphoma 2 (Bcl-2)
family has been identified with a definitive role in governing
oocyte survival and the maintenance of the ovarian reserve.
Bcl-2l2/Bcl-w and Bcl-2-l10/Diva deficiency had no apparent
impact on the ovarian reserve, and although ablation of Bcl-2
led to a loss of one-third of the adult PMF pool, the growing
follicle pool was not significantly impacted and these animals
did not undergo POF.16–19 Conditional Bcl-x (Bcl-2l1) inactivation led to increased primordial germ cell apoptosis in the
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embryo,20 but postnatal inactivation of Bcl-x in oocytes did not
compromise the ovarian reserve in young females.21 Bcl2a1a/
Bfl-1/A1 was low to undetectable in fully grown germinal
vesicle (GV) or ovulated murine oocytes,22 however, the
impact of Bfl-1 deficiency on the ovarian reserve has not yet
been analyzed to the best of our knowledge. Consequently,
either various anti-apoptotic Bcl-2 members have overlapping
roles in governing postnatal oocyte survival and maintenance
of the adult ovarian reserve in mice, or the anti-apoptotic Bcl-2
member that regulates this decision has yet to be identified.

Results
Myeloid cell leukemia-1 (MCL-1) in oocytes is reduced in
association with aging and activation of follicle atresia.
With the majority (99%) of all oocytes undergoing some form
of programmed cell death (PCD),3,13–15,23 and only a few
Bcl-2 family members identified with roles in regulation of
germ cell fate,16–21 we set to investigate which members of
the anti-apoptotic Bcl-2 gene family decline with maternal age

in human GV stage oocytes. A reduction in age-dependent
oocyte quality has been previously associated with activation
of cell death or molecular pathways that regulate this fate.8,10
From the analyzed targets (BCL-2, BCL-2L1, BCL-2L10,
BCL-2L11 and MCL-1), only the MCL-1 transcript significantly declined in an age-associated manner, with a
decrease in MCL-1 immunoreactivity in human GV oocytes
(Figure 1a). Changes in MCL-1 transcript associated with
differences in clinical diagnoses, stimulation protocol or
resultant outcome proved nonsignificant (Supplementary
Table S2). MCL-1 has been shown to be expressed by fetal
human and neonatal mouse oocytes,16,24 and abundant
transcript levels were detected in ovulated human oocytes.25
We assessed the expression of MCL-1 in murine ovaries
and before pubertal onset cytoplasmic immunoreactivity of
MCL-1 in oocytes increased with activation of follicle growth
(from PMF to primary follicle (PF)), remained robust in the
fully grown oocytes of preantral (PA) follicles and virtually
disappeared from oocytes undergoing atresia (Figure 1b).
This pattern indicated that MCL-1 could be an essential
regulator of oocyte survival.

Figure 1 Patterns of MCL-1 expression in human and murine oocytes. (a) Age-associated changes in MCL-1 transcript (left) and MCL-1 protein immunoreactivity (right) in
human GV oocytes from different patients. Pearson analysis revealed a negative correlation between MCL-1 transcript level and maternal age (n = 24; r = − 0.431; P = 0.035).
(b) Immunohistochemical staining of MCL-1 (brown) in 3-week ovarian sections of wild-type mouse ovaries, counterstained with hematoxylin (blue). PMF oocytes (arrows), PF
(PF) and PA follicles (arrowheads), and oocytes undergoing early stages of atresia (red arrowhead). At least three ovaries were stained per age group with identical expression
patterns
Cell Death and Disease
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Oocyte-specific Mcl-1 deficiency reduces ovarian follicle
pool, ovulation and fertility. To determine the functional
requirement for Mcl-1 in oogenesis, we created a mouse
model with oocyte-specific excision of Mcl-1 using zona
pellucida 3 (Zp3)-Cre. We confirmed spatial and temporal
activity of the Cre transgene by introduction into two reporter
lines, tdTomato and lacZ/alkaline phosphatase reporter
(Z/AP). Initial activation of Cre excision in oocytes was
observed as early as embryonic day 17.5, with a large
proportion of oocytes showing excision by postnatal day 3
(PN3; Supplementary Figure S1A). The selectivity of excision
was also confirmed in the adult Z/AP reporter line, with
excision in virtually all growing oocytes (Supplementary
Figure S1B). We next combined the Zp3-Cre allele with
floxed Mcl-1 (Mcl-1f/f). Effective excision was confirmed by
lack of MCL-1 immunoreactivity in oocytes of Mcl-1f/ − :
Zp3-Cre (Mcl-1 conditional knockout (Mcl-1cKO)) females
(Supplementary Figure S1C).
To determine the impact of Mcl-1 oocyte-specific deletion on
fertility, Mcl-1cKO and control females were bred to wild-type
males of proven fertility for a period of 6 months. The
cumulative breeding performance of Mcl-1cKO dams was
markedly reduced with an average of two litters during this
period, and each with less than half of the pup number
obtained from control females (Figure 2a, Supplementary
Figure S2A). In addition, Mcl-1cKO females did not deliver any
live litters beyond 4 months of age, whereas all control females
of the various genotypes were able to breed beyond 1 year of
age (Supplementary Figure S2A). Mcl-1 excision was confirmed in all genotyped Mcl-1cKO offspring (n = 31). To
establish whether the reduction in breeding performance
was due to an overall reduction in the ovulatory capacity,
females were primed with external gonadotropins and their
ovulatory response quantitated. We used females of various
age groups (at 6 and 3 months, as well as 3 weeks) as these
represented mature females, at a young reproductive age and
at pubertal onset, respectively. In Mcl-1cKO females, very poor
ovulatory capacity was observed at 3 months and ovulation
was virtually absent by 6 months (Figure 2b, Supplementary
Figure S2B). Histological examination revealed a severe
depletion in PMF, PF and secondary follicles (SF) and a
drastic reduction in ovary size already evident at 3 months of
age (Figure 2c, Supplementary Figure S2D). Furthermore, a
significant reduction of PMFs and PFs was also observed
in heterozygote females (Supplementary Figure S2C).
Interestingly, at the onset of puberty (3 weeks), females of all
genotypes ovulated comparable numbers of oocytes
(Supplementary Figure S2E), yet histomorphometric analyses
revealed a sharp reduction in PMFs and a significant decrease
in growing follicle number (Figure 2d). The loss of growing
oocytes may be partially due to an increased rate of atresia, as
a significantly higher proportion of late-stage atretic follicles
was observed (Figure 2f).
The loss of the resting PMF pool was the most marked
outcome we have observed. At PN7, only about half of the
PMFs were present with no change in the PF or SF population
(Figure 2e). This, combined with terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) analyses of
ovaries at PN1 revealing that Mcl-1 deficiency resulted in a
doubling of the number of apoptotic (TUNEL positive) oocytes

compared with controls (Figure 2g, Supplementary Figure S2F),
led us to conclude that Mcl-1 is required for postnatal
maintenance of the ovarian reserve.
Mcl-1 deficiency leads to elevated activation of autophagy in antral follicle population. Based on our observations that Mcl-1 ablation resulted in mildly elevated atresia
rates, and that MCL-1 expression was absent from oocytes
undergoing atresia, we next assessed markers of PCD in the
growing follicle pool. As PMF oocytes of Mcl-1cKO ovaries
die via an apparent apoptotic cell death, we set to investigate
whether antral GV oocytes also activate this death pathway.
Relative to controls, Mcl-1cKO oocytes exhibited an increase
in Bcl-2-associated X protein (BAX)-NT, indicative of a
conformational change in the N-terminus of BAX and
potentiating oligomerization; however, downstream hallmarks
of mitochondrial engagement (e.g., cytochrome C or
apoptosis-inducing factor (AIF) release) showed no significant change, with no increase in pan-caspase activity
(Supplementary Figures S3A–D). This data effectively
demonstrates that despite BAX activation, there is no
subsequent instigation of the apoptotic cascade in antral
Mcl-1cKO GV oocytes.
As follicle atresia exhibits hallmarks of both autophagic
(PCD type 2) and apoptotic (PCD type 1) cell death13 and
Mcl-1 has been previously linked to inhibition of both
pathways,26–28 we turned to the assessment of markers of
autophagic activation in GV oocytes. Induction or phosphorylation of Beclin-1/BECN-1 has been shown to initiate
autophagosome formation,29 and MCL-1 binding and inhibition of Beclin-1 prevented autophagy.27 Mcl-1cKO oocytes
displayed an increase in size and number of Beclin-1 foci,
indicating an increase in Beclin-1-associated vesicle formation (Figure 3a,Supplementary Figure S3F). In addition,
microtubule-associated protein 1 light chain (MAP1LC3A),
involved in autophagosome membrane elongation,30 was
elevated in Mcl-1cKO GV oocytes (Supplementary Figure
S3E). We next examined markers of late autolysosomes.
Lysosome-associated membrane proteins 1 and 2 (LAMP-1,
LAMP-2) are an essential part of autophagosome maturation,
autolysosome formation and lysosomal fusion.31 Mcl-1cKO
GV oocytes showed an increased number of foci positive for
both Beclin-1 and LAMP-2 (Figure 3a). Colocalization
analyses performed on 3D rendered oocyte sections confirmed a significant increase in Beclin-1/LAMP-2 colocalization in Mcl-1cKO GV oocytes. These colocalization analyses
also demonstrated that oocytes possessing just one Mcl-1
allele (Mcl-1f/+: Zp3-Cre), display an intermediary phenotype
(Supplementary Figure S3F). The amplified abundance of
autolysosome structures in Mcl-1cKO oocytes was further
validated by transmission electron microscopy (Figure 3b).
The elevation in number of Beclin-1-positive foci, LC-3
immunoreactivity and Beclin-1/LAMP-2 colocalized structures, indicates an augmentation of autophagosome and
autolysosome formation, triggered by Mcl-1 deficiency.
Ovulated Mcl-1-deficient oocytes display mitochondrial
dysfunction and chromosomal abnormalities. Despite
the marked loss of the ovarian pool at a young age,
Mcl-1cKO females do ovulate and breed, albeit at reduced
Cell Death and Disease
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efficiencies. As oocyte quality and reproductive competence
have been suggested to rely on effective mitochondrial
metabolism,32–34 and Mcl-1 has been implicated in regulation
of mitochondrial function in somatic cells,28,35,36 we assessed
these parameters in Mcl-1cKO ovulated oocytes. Using a

Cell Death and Disease

mitochondrial membrane potential sensitive dye, we
observed two distinct patterns of DePsipher fluorescence
(Figure 4a). Control oocytes displayed a strong centrally
localized inactive mitochondrial pool (green) with enrichment
of polarized mitochondria (red) in the cortical region (pattern 1).
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Conversely, many Mcl-1cKO oocytes exhibited a weak
diffuse distribution of inactive mitochondria (green) and
extremely few peripherally active polarized mitochondria
(red) (pattern 2). Moreover, the number of peripheral
polarized mitochondrial foci was significantly decreased in
Mcl-1cKO oocytes compared with controls (Figure 4a,
Supplementary Figure S4A). A decline in the respiring
mitochondrial pool, evidenced by decreased MitoTracker
Red intensity was also observed in Mcl-1cKO metaphase II
(MII) oocytes (Figure 4b,Supplementary Figure S4C). This
decrease was significant despite a marked elevation in
the total mitochondrial pool demonstrated by increased

MitoTracker Green (Supplementary Figure S4B), a dye that
binds mitochondrial membranes irrespective of their activity.
In measuring mitochondrial output, Mcl-1cKO MII oocytes
presented with a sharp reduction in levels of the TCA
cycle substrates fumarate and malate (Figure 4c), but
showed no apparent difference in total ATP level or
citrate (Supplementary Figure S4D), when compared with
control, implying no change in available energy. In addition,
total reactive oxygen species (ROS) and mitochondrialderived superoxides were markedly increased (Figure 4d,
Supplementary Figures S4E and 4F). High ROS levels can be
indicative of defective antioxidant machinery or an inhibition/

Figure 3 Markers of autophagy in GV oocytes. (a) Confocal image of Beclin-1 (red) and LAMP-2 (green) foci in isolated GV oocytes from 3-week ovaries, counterstained with
DAPI (blue). To determine colocalization, 3D rendering of all layers was performed on n = 19 Mcl-1cKO and n = 13 Mcl-1+/+GV oocytes with colocalized (yellow) pixels displayed.
Coefficients of colocalization for Mcl-1cKO oocytes compared with Mcl-1+/+(Pearsons (PCC) = 0.51 ± 0.05 to 0.17 ± 0.07, respectively; Po0.001) (Manders A (MCCA) = 0.098 ± 0.017 to 0.058 ± 0.01, respectively; Po0.05) (Manders B (MCC-B) = 0.079 ± 0.014 to 0.032 ± 0.005, respectively; Po0.05) (b) Transmission electron
microscopy (TEM) of Mcl-1cKO and wild-type control GV oocytes with lysosome-associated vesicles (red arrows) indicated

Figure 2 Breeding performance, ovulation rates and histomorphometric analyses of ovaries. (a) Cumulative pup number from Mcl-1cKO (n = 6) and Mcl-1+/+(n = 6) females
bred with wild-type males at 4 weeks for 6-month trial. Columns represent individual females with each varied color segment indicative of individual litters. (b) Ovulation rates from
primed 6-month Mcl-1cKO (n = 12), compared with Mcl-1+/+ (n = 18) control females and 3-month Mcl-1cKO (n = 20), compared with Mcl-1+/+ (n = 12) females. Values
represent average oocytes ovulated per female ± S.E.M. (c) Histomorphometric analyses of PMF, PF, SF and PA follicles in 3-month Mcl-1cKO (n = 5), compared with Mcl-1+/+
(n = 3) females; (d) in 3-week ovaries of Mcl-1cKO (n = 5) to Mcl-1+/+ (n = 4) females; (e) and in day 7 (PN7) Mcl-1cKO (n = 4), compared with Mcl-1+/+ (n = 4) females. Values
in c, d and e represent average number of follicles/ovary ± S.E.M. (f) Representative stages of follicle atresia (left) in ovarian sections stained with methyl green, display granulosa
cell death/detachment (arrows) preceding oocyte shrinkage (arrowhead). Both early and late-stage follicle atresia rates of Mcl-1cKO (n = 4), compared with Mcl-1+/+ (n = 5)
ovaries. Atretic follicles were taken as a proportion of the total post-secondary growing follicles and separated into advanced stage (late) or early/moderate stage follicle atresia.
(g) Death rates based on TUNEL stain of PN1 ovaries of Mcl-1cKO (n = 4) compared with Mcl-1+/+ (n = 3) females counterstained with methyl green. Values represent average
percentage of TUNEL positive/total PMF per section ± S.E.M. Significance denoted by number of stars (*Po0.05, **Po0.01, ***Po0.001). Genotypes in legend apply to
all graphs
Cell Death and Disease
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block in the electron transport chain,37,38 and elevated ROS and
impaired oxidative phosphorylation have been linked with
defective development and meiotic spindle defects.33,39–41
Microtubule staining of the meiotic spindle apparatus

Cell Death and Disease

revealed increased chromosomal misalignments in Mcl-1cKO
oocytes compared with controls with misaligned chromosome
(s) not attached to spindle (Figure 4e, Supplementary
Figure S4G).
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Mcl-1-deficient ovulated oocyte pool displays elevated
markers of apoptosis and increased fragmentation rates.
Defective mitochondrial bioenergetics are expected to impair
oocyte survival, particularly after ovulation, when cumulus
cells stop directly providing oocytes with nutrients.42 Thus, we
decided to investigate whether the viability of ovulated
oocytes was compromised because of Mcl-1 deficiency.
In vitro culture revealed an inability of Mcl-1cKO MII oocytes
to sustain meiotic arrest over 24 h and an increased

propensity to undergo cellular fragmentation (Figure 5a). As
cellular fragmentation of oocytes is thought to occur via
apoptosis,43 we explored whether hallmarks of activation of
the apoptotic pathway could be detected. Indeed, ovulated
oocytes displayed an increase in BAX-NT (Figure 5b,
Supplementary Figure S5A) with no change in total BAX
levels (Supplementary Figure S5A), accompanied by an
increase in mitochondrial cytochrome C release (Figure 5c,
Supplementary Figure S5B) and caspase activity (Figure 5d,

Figure 5 Markers of apoptosis in ovulated oocytes. (a) Oocytes obtained from Mcl-1cKO (n = 6), Mcl-1+/+ (n = 9), Mcl-1+/+: Zp3-Cre (n = 8), and Mcl-1f/+: Zp3-Cre (n = 4)
females (n = 104, n = 180, n = 241 and n = 69 oocytes, respectively) were scored 24 h after in vitro culture for percentage of fragmented oocytes ± S.E.M. per female/genotype.
(b) Mcl-1cKO (n = 12) and Mcl-1+/+ (n = 13) MII oocytes were stained with anti-BAX-NT (green), counterstained with DAPI (blue). Mean intensity was quantitated as fold change
of RFUs per oocyte ± S.E.M. normalized to average Mcl-1+/+ value. (c) Mcl-1cKO (n = 19) and Mcl-1+/+ (n = 33) MII oocytes were stained for total, and Mcl-1cKO (n = 13) and Mcl-1+/+
(n = 31) oocytes, were stained for retained Cytochrome c (green). Values represent the average fold change of RFUs per oocyte ± S.E.M. of retained/total cytochrome c, normalized to
average Mcl-1+/+ value. (d) Mcl-1cKO (n = 16) and Mcl-1+/+ (n = 13) MII oocytes were stained for pan-caspase activity (green). Values indicate average fold change of RFUs per
oocyte ± S.E.M. normalized to average Mcl-1+/+ value (*Po0.05, **Po0.01, ***Po0.001). Genotypes in legend apply to all graphs

Figure 4 Markers of mitochondrial function and chromosomal alignment. (a) Mcl-1cKO (n = 57) and Mcl-1+/+ (n = 85) MII oocytes were stained with a potential dependent
mitochondrial dye (DePsipher). Values in graph (left) represent a proportion (%) of oocytes with few (o20) or numerous (420) polarized (red) mitochondrial foci ± S.E.M. per
Mcl-1cKO or Mcl-1+/+ oocytes. Values in graph (right) represent the proportion (%) of oocytes with mitochondrial distribution separated into pattern 1 or pattern 2 ± S.E.M. (b)
Mean intensity of Mcl-1cKO (n = 68) and Mcl-1+/+ (n = 52) MII oocytes stained with MitoTracker Red. Values represent average fold change ± S.E.M. of relative fluorescence
units (RFUs) per oocyte, normalized to wild type. (c) Mcl-1cKO (n = 15) and Mcl-1+/+ (n = 15) oocytes were assayed for levels of TCA cycle substrates malate and fumarate.
Values represent average metabolite level (μmol) per oocyte wet weight (kg) ± S.E.M. (d) MII oocytes were stained with DCFDA (green) (Mcl-1cKO (n = 20) and Mcl-1+/+
(n = 17)) or with MitoSox (red) (Mcl-1cKO (n = 20) and Mcl-1+/+ (n = 24)). Values represent average fold change ± S.E.M. of RFUs per oocyte, normalized to wild type. (e) MII
oocytes were stained with DAPI (red) and anti-tubulin (green) to visualize chromatin and spindle; chromosomal misalignments (white arrow) from Mcl-1cKO (n = 84) and Mcl-1+/+
(n = 89) oocytes were quantitated. Values represent percentage of oocytes with misaligned chromosomes/total oocyte pool. (*Po0.05, **Po0.01, ***Po0.001). Genotypes in
legend apply to all graphs
Cell Death and Disease
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Figure 6 Rescue of Mcl-1-deficient follicle loss by concurrent Bax ablation. (a) Histomorphometric analyses of 3-month ovaries in Mcl-1cKO (n = 5), Mcl-1+/+(n = 3) and Mcl1c/BaxDKO (n = 3) females. Values represent average follicle number in ovary per genotype ± S.E.M. (b) Ovulation rates of Mcl-1cKO (n = 20), Mcl-1+/+(n = 12) and Mcl-1c/
BaxDKO (n = 3) 3-month females. Values represent average number of ovulated oocytes ± S.E.M. (c) MII oocytes from Mcl-1cKO (n = 6), Mcl-1+/+(n = 10) and Mcl-1c/BaxDKO
(n = 3) females (n = 104, n = 180, n = 48 oocytes, respectively) cultured for 24 h and values represent the average percentage of fragmented oocytes per female ± S.E.M. (d)
Mcl-1cKO (n = 50), Mcl-1+/+(n = 33), and Mcl-1c/BaxDKO (n = 49) MII oocytes were stained with MitoTracker Red. Values represent fold change of average RFUs per
oocyte ± S.E.M. normalized to average Mcl-1+/+ value. (e) Chromosomal misalignments in Mcl-1cKO (n = 70), Mcl-1+/+ (n = 89) and Mcl-1c/BaxDKO (n = 19) oocytes were
quantitated (from n = 4, n = 5 and n = 2 animals, respectively). Values represent percentage of oocytes with misaligned or normal chromosomes/total oocyte pool. Mcl-1c/
BaxDKO data were all graphed against Mcl-1cKO and Mcl-1+/+data from Figures 2,4 and 5. (*Po0.05, **Po0.01, ***Po0.001). Genotypes in legend apply to all graphs

Supplementary Figure S5C). Thus, Mcl-1 deficiency in
ovulated MII oocytes leads to an activation of the apoptotic
cascade, and an increased proclivity for these compromised
oocytes to fragment.
Concurrent deletion of Bax rescues ovarian follicle loss
and increased fragmentation rate but does not impact
mitochondrial dysfunction or chromosome abnormalities. Deletion of the pro-apoptotic Bcl-2 family member Bax
rescues the primordial germ cell loss induced by ablation of
the anti-apoptotic Bcl-x.20 By itself, Bax deficiency has been
linked to increased primordial germ cell survival,44 resulting in
an increase in follicular endowment45 and extended ovarian
function to advanced chronological age.46 In order to
evaluate whether Bax deficiency would also rescue loss of
the ovarian reserve in Mcl-1cKO females, we crossed a Baxdeficient line to our Mcl-1cKO mouse line. Ovaries from
3 month Bax−/−(Bax knockout (BaxKO)), Mcl-1f/ − : Bax−/−:
Zp3-Cre (double knockout with conditional Mcl-1 and total
Bax deletion (Mcl-1c/BaxDKO)), Mcl-1cKO females and
controls were used for histomorphometric ovarian analyses.
Bax deficiency alone substantially increased the cohort of
Cell Death and Disease

PMFs; and the Mcl-1c/BaxDKO ovarian reserve resembled
BaxKO ovaries in all follicle numbers, implying a rescue of the
Mcl-1-deficient oocyte phenotype (Figure 6a, Supplementary
Figure S6A). Moreover, Mcl-1c/BaxDKO females displayed
restored ovulation rates (Figure 6b, Supplementary Figure
S6B), and a resiliency of MII oocytes against cellular
fragmentation during in vitro culture, akin to wild-type controls
and BaxKO (Figure 6c, Supplementary Figure S6C). However, despite a very robust rescue to the ovarian follicle pool,
Bax deficiency was not able to restore mitochondrial
functionality (Figure 6d, Supplementary Figure S6D) or
correct the choromosomal misalignments (Figure 6e) in
ovulated oocytes, indicating that, in oocytes, Mcl-1 regulates
additional aspects of cellular and mitochondrial physiology
independent of Bax or cell death. Indeed, breeding trials of
older (4- to 8-month old) BaxKO or Mcl-1c/BaxDKO mice
revealed a longer breeding expectancy, but not an increase in
the number of pups, as litter size remained o2. Although no
Mcl-1cKO mice (n = 8) produced litters after 4 months of age,
two out of three Mcl-1c/BaxDKO females produced at least
one litter during the 3-month breeding trial (Supplementary
Table S1).
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Discussion
Limited ovarian phenotypes caused by deletion of antiapoptotic Bcl-2 members16–19,21 has led to the postulation
that they are either uninvolved or redundant in postnatal
oocyte survival. Mcl-1 has a well-documented cell survival role
for numerous somatic cell types;36,47,48 however, its necessity
for long-term germ cell viability has not been established. We
present evidence of Mcl-1 as the first pro-survival Bcl-2
member required for life-time maintenance of the ovarian
reserve and stage-specific inhibition of varying modes of
oocyte cell death.
As demonstrated above, cytoplasmic MCL-1 expression
increases during the transition from PMF to PF, and continues
to accumulate with sustained follicle growth; but oocytes in
atretic follicles lack MCL-1 indicating that downregulation of
MCL-1 could precede initiation of oocyte atresia. Mcl-1
appears to mediate PMF survival by antagonizing Bax action,
as Mcl-1 deficiency-induced PMF loss by apoptotic oocyte
death, was restored by concurrent Bax ablation. Those Mcl-1deficient oocytes that escape the early PMF demise and begin
to grow, exhibit increased markers of cellular autophagy
without apoptotic activation, resulting in only mildly elevated
rates of atresia. This lack of apoptotic activation may in part be
due to additional anti-apoptotic Bcl-2 members neutralizing
activated BAX in the absence of MCL-1, or via additional
undetermined mechanisms. We also show that the ability to
initiate the apoptotic cascade does not occur till ovulation, as
meiotic completion is essential for apoptotic activation.49,50
We postulate that Mcl-1-deficient GV oocytes activate the
autophagic machinery in response to mitochondrial dysfunction accompanied by disruption of metabolic machinery,
however, we cannot exclude the possibility that Mcl-1 can
directly regulate autophagy. Deletion of Mcl-1 has been
recently linked to elevated mitochondrial dysfunction and
activation of either autophagy or apoptosis in a stress- and
cell-specific manner in cardiomyocytes, cortical neurons and
MEFs.28,35,36 When evaluated, these phenotypes were
accompanied by disruption of mitochondrial membrane
potential, defective ATP output and production of superoxides.
Mitochondrial bioenergetic output and functionality have long
been considered essential factors in mediating oocyte quality
and reproductive competence.32,33 Mcl-1cKO oocytes display
enhanced mitochondrial dysfunction; with elevated superoxides, impaired mitochondrial activity and reduced fumarate
and malate, associated with chromosome abnormalities and
elevated MII oocyte fragmentation; the last phenotype alone
being mitigated by concurrent Bax deficiency. These mitochondrial phenotypes may be regulated by a newly identified
matrix-localized isoform of MCL-1, associated with prevention
of defective complex II enzymatic activity and disrupted
supercomplex assembly.35 Confirmation of a role for this
isoform in oocytes is yet to be determined. As oocyte-cumulus
cell contact is required for the continuance of meiotic arrest,
oocyte growth51,52 and regulation of metabolite supply to the
oocyte,53–56 it is conceivable that maintained granulosa/
cumulus cell support permits the Mcl-1-deficient immature
oocytes to prolong their demise and, in conjunction with
activation of autophagy, compensates for associated metabolic deficiencies. Subtle changes in ATP levels57,58 and relief

of MCL-1 inhibition of Beclin,27,28 could be sufficient for
autophagic activation in Mcl-1-deficient oocytes.
Additional studies are required to elucidate whether the
maintenance of mitochondrial dysfunction with concomitant
Bax deficiency may be due to a BAX-independent function of
MCL-1, an additional role of BAX in mitochondrial function59 or
some combination of both. As breeding was prolonged but not
fully rescued by Bax deficiency, it indicates that although
oocyte death could be prevented by Bax ablation, additional
roles of Mcl-1, independent of Bax, are present, and may also
govern embryo development.60 It would also be very
informative to determine if depletion of Bok, another multichannel pro-apoptotic member of Bcl-2 gene family, could
rescue the developmental competence of Mcl-1-deficient
oocytes. It should also be noted that in keeping with previous
data,46 Bax-deficient females do display variable breeding
performance.
Fertility and reproductive proficiency has been well established to rely on the maintenance of the ovarian reserve in
addition to preservation of oocyte quality. We observed a
correlation between maternal age and MCL-1 expression
levels in human oocytes, and our animal model demonstrates
that oocyte-specific ablation of Mcl-1 results in the accumulation of defects associated with compromised oocyte
quality.6,7,9,10,61 Furthermore, we establish that Mcl-1 has
the defining role in mediation of oocyte survival via protection
of the postnatal PMF pool, in addition to the growing and
ovulated oocyte pool. Thus, investigation into modulation of
Mcl-1 expression by oocytes could prove informative in
understanding what factors may contribute to POF and agerelated oocyte loss.
Materials and Methods
Animals. Mcl-1tm3Sjk (Mcl-1fl)47 mice carrying the floxed allele were obtained
from the breeding colony of Dr. Korsmeyer and were intercrossed to mice carrying
the Tg(Zp3-Cre)3Mrt (Zp3-Cre) transgene62 and to Baxtm1Sjk mice.63 All mice were
housed with free access to food and water and maintained on a 12- h:12- h light–
dark cycle. All mouse experiments were performed in accordance with the Canadian
Council on Animal Care (CCAC) guidelines for Use of Animals in Research and
Laboratory Animal Care, under protocols approved by animal care committees of
the Toronto Centre for Phenogenomics (TCP). To assess timing of excision, Zp3-Cre
mice62 were also crossed to reporter lines Tg(CAG-Bgeo/ALPP)1Lbe (Z/AP)64 and
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze (tdTomato).65
Animals were genotyped for possession of either Mcl-1+ or Mcl-1f alleles using
primers 5'-CTGAGAGTTGTACCGGACAA-3' (7MCL1) and 5'-GCAGTACAGGTTCA
AGCCGATG-3' (6MCL1), and for Mcl-1null (Mcl-1− ) allele using primers 7MCL1 and
5'-ACGCTCTTTAAGTGTTTGGCC-3' (2MCL1). Presence of Zp3-Cre transgene was
assessed using 5'-TGATGAGGTTCGCAAGAACC-3' (CREF) and 5'-CCATGAGT
GAACGAACCTGG-3' (CRER) and genotyping for Bax+ and Bax − alleles utilized
5'-GAGCTGATCAGAACCATCATG-3' (BAX-EX5-F), 5'-GTTGACCAGAGTGGCG
TAGG-3' (BAX-LN5-R) and 5'-CCGCTTCCATTGCTCAGCGG-3' (BAX-NEO).
Collection of oocytes and breeding. Immature (GV) oocytes were
collected from antral follicles 46–48 h after pregnant mare’s serum gonadotropin
(PMSG; NHPP, Torrance, CA, USA or ProSpec, Rehovot, Israel (HOR-272)) priming
and manually stripped of cumulus cells using narrow glass pipettes. For mature
ovulated oocytes (MII), human chorionic gonadotropin (Sigma, Oakville, ON,
Canada) priming was performed 44–48 h after PMSG and oocytes collected
14–16 h later; with cumulus removed by incubation in Hyaluronidase (Sigma). MII
oocyte fragmentation rates were performed by MII culture in HTF media (Life
Global, Guilford, CT, USA) supplemented with 0.1% BSA (Sigma) for 24 h. For
breeding rates, dams at 4–5 weeks were mated to young wild-type males for a
6-month breeding trial and total litter number and size recorded. For Mcl-1c/
BaxDKO or BaxKO breedings, dams at 4–8 months of age were bred to wild-type
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(Mcl-1f/+) males for 2–3 months and litters were recorded. Immature human
oocytes, obtained from patients undergoing IVF treatment, were donated to
research after obtaining patient consent approved by the Research Ethics Board at
Mount Sinai Hospital, Toronto. Details of gene expression studies are
described below.
Real-time PCR with human oocytes. Obtained single human oocytes at
GV stage free of cumulus cells were loaded into guanidine iso-thiocyanate solution
and total nucleic acids were precipitated using glycogen as a carrier.22 Upon
treatment with DNase (Sigma-Aldrich, St. Louis, MO, USA), reverse transcription
was performed on the whole sample using Revert Aid Kit (Fermentas, Invitrogen
Life Technologies, Burlington, ON, Canada) and oligo-dT primers. cDNA product
was used in a real-time PCR reaction using LightCycler 480 SYBR Green I Master
(Roche Applied Science, Indianapolis, IN, USA) and LightCycler 480 (Roche,
Mannheim, Germany). The amplification profile included a pre-incubation step at
95 °C for 5 min, followed by denaturation at 95 °C, annealing at 62 °C and extension
at 72 °C. The target gene concentration for the oocyte samples was extrapolated
utilizing the standard curve for each target and the data were expressed as relative
ratio to CP value of β-ACTIN. Primer sequences for all genes analyzed
(Supplementary Table S3).
Histological ovarian analyses. Ovaries from Mcl-1f/ − : Zp3-Cre (Mcl1cKO), Mcl-1f/ − , Mcl-1f/f, Mcl-1+/+, Mcl-1+/+: Zp3-Cre, Mcl-1f/+: Zp3-Cre, Bax −/−,
Mcl-1f/+: Bax−/−: Zp3-Cre and Mcl-1f/ − : Bax−/−: Zp3-Cre females were collected at
varying timepoints (6 months, 3 months, 3 weeks, PN14 or PN7) and fixed in
Dietrichs (4% formalin, 28% EtOH, 0.34N Glacial Acetic Acid (Sigma)) or 10%
formalin (Fisher, Ottawa, ON, Canada) and following standard dehydration protocols
were embedded in paraffin wax and sectioned (5 μm) using a LEICA (Concord, ON,
Canada) RM2255 Microtome and then mounted on Superfrost plus slides. Sections
fixed in Dietrichs were rehydrated and stained with a picric acid/methyl blue stain,
allowing for better resolution for histomorphometric analyses. Every third section
was counted for PN7 and PN14 ovaries, every fifth section counted for 3 weeks
ovaries, and every 10th section for 3 months and 6 months. Oocytes with visible
nuclei from primordial, primary, secondary and antral follicles were quantitated and
recorded and multiplied by associated factor (x3, x5 and x10) to gain an
approximately full representation of the ovary. Atretic follicles were counted in
sections from 3-week ovaries and are shown as a proportion of the total postsecondary growing follicles.
Ovaries from embryonic day 17.5 and PN3 tdTomato: Zp3-Cre animals were
removed from animals and washed in mHTF. Entire tissue samples were viewed
under LEICA DMI60003 Spinning Disc Confocal or LEICA MZ 165A Stereomicroscope using TRITC-Red laser (561 excitation, 620 emission), and imaged.
Cryosections of ovaries from Z/AP: Zp3-Cre mice were postfixed in 0.2%
glutaraldehyde and endogenous alkaline phosphatase (AP) activity was inactivated
by heating for 30 min in PBS at 70 °C and then rinsed in PBS. Sections were then
washed in buffer (100 mM Tris-HCL pH 9.5, 100 mM NaCl, 10 mM MgCl2) for 10 min
and stained with NBT/BCIP stain, washed in PTM (0.1%Tween20, 2 mM MgCl2, in
PBS) and counterstained with Nuclear Fast Red.
Sections fixed in 10% formalin were rehydrated and used for immunohistochemical
staining protocols. Sections were submitted to antigen retrieval at ~ 95 °C for 10 min
in sodium citrate buffer (10 mM tri-sodium citrate (Sigma) pH 6.0 with HCl), washed
and blocked in 10% normal horse serum (NHS) for 1 h before overnight incubation in
primary antibody (in 10% NHS) at 4 °C. Primary antibodies utilized include Mcl-1
(Rockland Immunochemicals, Limerick, PA, USA, 600-401-394S). Sections were then
washed in PBS and incubated with secondary protocols from ABC Vectastain kit
(PK-4001; Vector Labs, Burlington, ON, Canada) and then visualized using diaminobenzidine (DAB) (Sigma) substrate. After time-sensitive stain development, sections
were counterstained in hematoxylin (Sigma) for identification of cell nuclei.
TUNEL analyses. For detection of apoptotic cells, sections of PN1 ovaries
were fixed in formalin, rehydrated and incubated in Proteinase K followed by
permeabilization with 0.1% Triton-X. Slides were incubated in Reaction Mix (4 μM
biotin16-dUTP (Roche), 1.5 μM dATP, 1X NEB4 buffer, 4 U/ul TdT enzyme (Roche)
for 1.5 h at 37 °C and incorporated nucleotides were detected with streptavidin ABC
Vectastain (Vector Labs) and visualized with DAB.
Mitochondrial analyses – live cell stains. MII ovulated oocytes of
Mcl-1cKO and controls were collected and subjected to a number of assays for
determination of mitochondrial function. Total and respiring mitochondria were
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stained using Mitotracker fluorescent dyes (MitoTracker Green FM (M7154),
MitoTracker Red 580 (M22425); Molecular Probes, Invitrogen LifeTechnologies)
added to HTF in 100 nM concentration for 30 min, then washed in mHTF and
imaged. For total cellular levels of ROS, oocytes were incubated in 10 μM 2′, 7′dichlorofluorescein diacetate (DCFDA; Molecular Probes) or 5 μM MitoSox
(Molecular Probes) in HTF for 15 min, washed in mHTF and imaged. The
performance of fluorescent probes utilized for detection of ROS, and various
mitochondrial markers was validated (Supplementary Figures S5D and E), using MII
oocytes cultured in the presence of inducers of apoptosis or inhibitors of the
electron transport chain. Induction of apoptosis in ovulated oocytes was done as
previously described66 with 200 nM doxorubicin (DXR; Alexis, Enzo LifeSciences,
Farmingdale, NY, USA) for 20 h followed by incubation with MitoTracker Green,
MitoTracker Red, DCFDA or MitoSox. For disruption of mitochondrial function and
inhibition of electron transport chain, MII oocytes were incubated in 100 nM complex
III inhibitor Antimycin (Sigma) or vehicle (ethanol) for 15 min followed by coincubation with mitochondrial dyes. Death rates for MII oocytes with antimycin
treatment are included in Supplementary Figure S5E.
For mitochondrial membrane potential, MII oocytes were incubated with 5 μg/ml
DePsipher (DePsipher, Trevigen (6300-100-K, Gaithersburg, MD, USA)) in HTF for
90 min then washed and imaged. The mitochondrial fluorescent distribution of each
oocyte was visually separated into pattern 1 – oocytes with strong central green
fluorescence distribution and peripheral scattering of polarized mitochondria (red); or
pattern 2 – oocytes with diffuse distribution of green fluorescence and little to no
peripheral polarized mitochondria (red).
To assess metabolic profile citrate, malate and fumarate levels, MII oocytes were
first frozen on glass slides by dipping in cold isopentane. Oocytes were then freeze–
dried and processed for metabolic profile using protocol delineated in Chi et al.67 ATP
content in single oocytes was measured by Cell Titer GLO assay (Promega, Madison,
WI, USA).
Immunofluorescence staining. GV or MII oocytes from Mcl-1cKO and
control females were fixed in 10% formalin for 10 min and used for staining of
markers of apoptosis and autophagy. Oocytes were first transferred to cooling
~ 95 °C sodium citrate buffer for antigen retrieval for 10 min using pulled-glass
pipettes. Oocytes were moved to three washes in 0.1% Triton-X in 10 mM PBS and
then blocked in 10% NHS in PBS. Following this step, oocytes were incubated in
primary antibody overnight at 4 °C. Primary antibodies used include anti-Beclin-1
(Santa Cruz Biotechnologies, Dallas, TX, USA, sc-11427), anti-LC-3 (MBL, EMD
Millipore, Billerica, MA, USA, PM046), anti-Lamp1 (1D4B, Developmental Studies
Hybridoma Bank, Iowa City, IA, USA), anti-Lamp2 (ABL-93, Developmental Studies
Hybridoma Bank), anti-Bax-NT (Upstate, EMD Millipore; 06-49), anti-BAX (Alexis,
210-003), anti-tubulin (Invitrogen LifeTechnologies, A11126), anti-actin (Santa Cruz
Biotechnologies, sc-1616), anti-AIF (Santa Cruz Biotechnologies, sc-9416), antiMcl-1 (Santa Cruz Biotechnologies, sc-819) and anti-Mcl-1 (Rockland Immunochemicals, 600-401-394S). After primary antibody incubation, oocytes were
transferred to 0.1%TX washes and incubated in host-specific secondary antibody
conjugated with Alexa Fluor dyes (Invitrogen LifeTechnologies) and counterstained
with blue fluorescent 4′,6-diamidino-2-phenylindole (DAPI, Sigma). Stained samples
were mounted on slides in 50% glycerol for imaging. For negative controls, oocytes
were exposed to nonspecific IgG or secondary antibody alone.
For evaluation of apoptotic induction, cytochrome c release, AIF release and pancaspase activity assays were performed on GV and MII oocytes with protocols
modified from Carboxyfluorescein Multi-Caspase Activity Kit (Biomol, Enzo
LifeSciences) and cytochrome c release kit (InnoCyte – Calbiochem, EMD MIllipore).
A portion of denuded GV and MII oocytes were permeabilized for 10 min with digitonin
buffer. Both permeabilized and non-permeabilized oocytes were then fixed, and
processed through the staining. For AIF release, AIF (Santa Cruz Biotechnologies,
sc-9416) was utilized instead of cytochrome c antibody. For pan-caspase activity, GV
and MII oocytes were incubated in FML-VAD-FMK stock dissolved in HTF medium for
2.5 h and washed and transferred to fixative as indicated in caspase activity kit.
Oocytes were then washed and transferred to DAPI for 10–15 min, then mounted on
Superfrost slides in 50% glycerol and imaged, as mentioned previously. The efficacy
of these markers of apoptotic induction was verified (Supplementary Figure S5D),
using MII oocytes cultured in the presence of 200 nM DXR66 for 14 h (Bax,
cytochrome c) or 20 h (pan-caspase). MII oocytes incubated with DXR for 24 h
display death rates of 80%.
Imaging. Stained oocytes were imaged using LEICA DMI60003 Spinning Disc
Confocal microscope with appropriate filters (objectives: 10X/0.40NA, 20X/0.70NA).
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Images were acquired and analyzed using Volocity software (PerkinElmer, Waltham,
MA, USA) with Z-stack images taken at 0.354 μm increments across 10 μm
sections to the either side of the midpoint of the oocyte, and average mean
fluorescent intensity obtained from each sample was used for comparative purposes
and expressed as random fluorescent units (RFUs). Colocalization data images
were analyzed using Imaris (Bitplane, Zurich, Switzerland) software.
Histological ovarian sections were imaged with a LEICA/LEITX DMRXE
microscope (objectives: 5X/0.12 NA, 10X/0.30 NA, 20X/0.50 NA, 40X/0.85 NA,
63X/0.75 NA, 100X/1.30 NA). Whole ovary images of TdTomato: Zp3-Cre mouse
line and controls were acquired using the LEICA MZ16FA stereomicroscope
(objectives: 4X/0.45 NA), with appropriate filters.
Western blots. Two hundred GV oocytes from approximately 8–10 Mcl-1cKO
and Mcl-1+/+ females were collected and lysed in RIPA buffer. Lysates were
separated by SDS-PAGE and then transferred on to a PVDF membrane. Blots were
incubated with anti-Mcl-1 (Rockland Immunochemicals, 600-401-394S) or anti-actin
(Santa Cruz Biotechnologies, sc-1616). Membranes were washed and then
incubated with specific HRP-conjugated donkey anti-rabbit (Santa Cruz Biotechnologies) or HRP-conjugated donkey anti-goat (Santa Cruz Biotechnologies) and
detected using enhanced chemiluminescence (Thermo Scientific, Burlington, ON,
Canada) SuperSignal West Femto Chemiluminescent Substrate and then imaged
on the VersaDoc 5000MP Imaging System (Bio-Rad, Mississauga, ON, Canada).
Statistical analysis. Data were analyzed using either one-way ANOVA with
Holm–Sidak multiple comparisons test (Breeding performance, histomorphometric
analyses, PCC, PCC-C); or using non-parametric Kruskal–Wallis one-way ANOVA
on ranks, followed by Dunns post-hoc test for comparisons between groups, when
normality failed or sample sizes were vastly different (ovulation rates, active Bax
(GV), beclin, LC-3, MitoTracker green and red, active Bax (MII), fragmentation rates,
MCC-A, MCC-B, MitoSox, ROS, cytochrome c, caspase activity, chromosomal
misalignments). Statistical measures for two groups were performed using the
unpaired t-test (histomorphometric analyses, atresia rates, metabolites), two-way
ANOVA (DePsipher) or χ2 test (chromosome misalignments; Figure 6). Association
maternal age and gene expression was done by Pearson correlation. All analysis
was done using the Sigma Stat (Systat, San Jose, CA, USA) or PRISM software
package (Graph Pad, San Diego, CA, USA). In all cases, differences were
considered significant if value reached Po0.05.
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